Clinical Trial

High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients

Study acronym: TRACH2O
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This monocentric, randomized crossover study aims to assess the impact of high-flow tracheal therapy (HFT) on the rheological properties of tracheobronchopulmonary secretions in tracheostomized patients. The primary objective is to compare the viscoelastic characteristics of secretions collected with and without HFT. Secondary objectives include evaluating the effects of HFT on dyspnea, patient comfort, and secretion appearance. The study will take place at Cliniques Universitaires Saint-Luc, with adult tracheostomized patients undergoing standard care.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-20.
Trial Details
NCT Number NCT06897319
Lead Sponsor Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions Tracheostomized Patients
Enrollment 15 participants
Start Date 2026-06-20
Primary Completion 2027-08-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-27